Search Results - "Dhillon, Sharonjit K"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol by Dhillon, Sharonjit K, Simoens, Cindy, Cuypers, Lize, Bode, Jannes, Bonde, Jesper, Corbisier, Philippe, Cocuzza, Clementina E, Van Ranst, Marc, Arbyn, Marc

    Published in Virology journal (24-02-2023)
    “…The COVID-19 pandemic highlighted the importance of diagnostic testing against curbing the spread of SARS-CoV-2. The urgent need and scale for diagnostic tools…”
    Get full text
    Journal Article
  2. 2

    Evaluation of the Allplex HPV assay's adherence to international guidelines for cervical cancer screening in clinician-collected samples by Chung, Pui Yan Jenny, Dhillon, Sharonjit K, Cortoos, Selina, Hamerlinck, Hannelore, Pereira, Rita, Padalko, Elizaveta, Vanden Broeck, Davy, Arbyn, Marc

    Published in Microbiology spectrum (06-08-2024)
    “…Clinically validated human papillomavirus (HPV) assays are crucial in cervical cancer screening. In this study, we evaluated the Allplex HPV HR Detection assay…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework by Dhillon, Sharonjit K, Oštrbenk Valenčak, Anja, Xu, Lan, Poljak, Mario, Arbyn, Marc

    Published in Journal of clinical microbiology (19-05-2021)
    “…Only clinically validated human papillomavirus (HPV) tests should be used in cervical cancer screening. VALGENT provides a framework to validate new HPV tests…”
    Get full text
    Journal Article
  5. 5

    Intra‐ and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay by Dhillon, Sharonjit K., Chung, Pui Yan Jenny, Padalko, Elizaveta, Praet, Marleen, Pereira, Ana Rita, Redzic, Nina, Vanden Broeck, Davy, Arbyn, Marc

    Published in Journal of medical virology (01-09-2023)
    “…Abstract The implementation of cervical screening based on human papillomavirus (HPV) continues to progress rapidly across countries. Evidence has shown that…”
    Get full text
    Journal Article
  6. 6

    Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework by Dhillon, Sharonjit K., Cocuzza, Clementina E., Chung, Pui Yan Jenny, Martinelli, Marianna, Giubbi, Chiara, Njoku, Ruth C., Bhatia, Ramya, Cuschieri, Kate, Arbyn, Marc

    Published in Journal of medical virology (01-01-2023)
    “…Human papillomavirus (HPV) assays used in cervical cancer screening should be clinically validated according to international criteria. OncoPredict HPV®…”
    Get full text
    Journal Article
  7. 7

    The Sansure® Human Papillomavirus DNA Diagnostic Kit offers excellent reproducibility performance for the detection of high‐risk HPV by Prétet, Jean‐Luc, Baraquin, Alice, Chung, Pui Yan Jenny, Puget, Line, Dhillon, Sharonjit K., Tkachenka, Yuliya, Jacquot, Killian, Lepiller, Quentin, Broeck, Davy Vanden, Arbyn, Marc

    Published in Journal of medical virology (01-10-2024)
    “…Cervical cancer screening is a cornerstone of cervical cancer elimination. Detection of high‐risk human papillomavirus (hrHPV) is recommended as the first step…”
    Get full text
    Journal Article
  8. 8

    Intra‐ and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay by Chung, Pui Yan Jenny, Dhillon, Sharonjit K., Baraquin, Alice, Tkachenka, Yuliya, Jacquot, Killian, Prétet, Jean‐Luc, Broeck, Davy Vanden, Arbyn, Marc

    Published in Journal of medical virology (01-06-2024)
    “…To meet the screening goal of WHO's 90‐70‐90 strategy aimed at eliminating cervical cancer (CC) by 2030, clinical validation of human papillomavirus (HPV)…”
    Get full text
    Journal Article
  9. 9